REGENERON PHARMACEUTICALS, INC. Insider Trading for August 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REGENERON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in REGENERON PHARMACEUTICALS, INC. for August 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 29 2014 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Option Exercise | M | 314.31 | 5,720 | 1,797,853 | 0 | |
| Aug 29 2014 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Option Exercise | G | 0.00 | 23,367 | 0 | 23,367 | |
| Aug 29 2014 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Option Exercise | G | 0.00 | 23,367 | 0 | 0 | |
| Aug 29 2014 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Gift | G | 0.00 | 568,343 | 0 | 568,343 | 0 to 568.3 K |
| Aug 29 2014 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Payment of Exercise | F | 351.33 | 310 | 108,912 | 500,294 | 500.6 K to 500.3 K (-0.06 %) |
| Aug 29 2014 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Payment of Exercise | F | 351.33 | 5,116 | 1,797,404 | 500,604 | 505.7 K to 500.6 K (-1.01 %) |
| Aug 29 2014 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Buy | M | 314.31 | 5,720 | 1,797,853 | 505,720 | 500 K to 505.7 K (+1.14 %) |
| Aug 29 2014 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Gift | G | 0.00 | 568,343 | 0 | 500,000 | 1.1 M to 500 K (-53.20 %) |
| Aug 28 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | M | 30.63 | 56 | 1,715 | 3,264 | |
| Aug 28 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | M | 21.25 | 1,625 | 34,531 | 0 | |
| Aug 28 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Buy | M | 21.25 | 1,625 | 34,531 | 4,681 | 3.1 K to 4.7 K (+53.17 %) |
| Aug 28 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Buy | M | 30.63 | 56 | 1,715 | 3,056 | 3 K to 3.1 K (+1.87 %) |
| Aug 27 2014 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Option Exercise | M | 11.64 | 303,909 | 3,537,501 | 0 | |
| Aug 27 2014 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Payment of Exercise | F | 351.62 | 151,537 | 53,283,440 | 390,852 | 542.4 K to 390.9 K (-27.94 %) |
| Aug 27 2014 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Payment of Exercise | F | 351.62 | 10,060 | 3,537,297 | 542,389 | 552.4 K to 542.4 K (-1.82 %) |
| Aug 27 2014 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Buy | M | 11.64 | 303,909 | 3,537,501 | 552,449 | 248.5 K to 552.4 K (+122.28 %) |
| Aug 27 2014 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Option Exercise | M | 50.91 | 3,000 | 152,730 | 12,279 | |
| Aug 27 2014 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Option Exercise | M | 50.91 | 1,387 | 70,612 | 15,279 | |
| Aug 27 2014 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Sell | S | 352.20 | 3,000 | 1,056,600 | 1,187 | 4.2 K to 1.2 K (-71.65 %) |
| Aug 27 2014 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Buy | M | 50.91 | 3,000 | 152,730 | 4,187 | 1.2 K to 4.2 K (+252.74 %) |
| Aug 27 2014 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Payment of Exercise | F | 351.62 | 200 | 70,324 | 1,187 | 1.4 K to 1.2 K (-14.42 %) |
| Aug 27 2014 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Buy | M | 50.91 | 1,387 | 70,612 | 1,387 | 0 to 1.4 K |
| Aug 27 2014 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Sell | S | 350.31 | 2,000 | 700,620 | 4,000 | 6 K to 4 K (-33.33 %) |
| Aug 26 2014 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Option Exercise | M | 24.00 | 3,000 | 72,000 | 8,064 | |
| Aug 26 2014 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Buy | M | 24.00 | 3,000 | 72,000 | 18,600 | 15.6 K to 18.6 K (+19.23 %) |
| Aug 19 2014 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Option Exercise | M | 52.03 | 8,750 | 455,263 | 26,250 | |
| Aug 19 2014 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Sell | S | 350.00 | 3,611 | 1,263,850 | 15,600 | 19.2 K to 15.6 K (-18.80 %) |
| Aug 19 2014 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Payment of Exercise | F | 351.06 | 3,843 | 1,349,124 | 19,211 | 23.1 K to 19.2 K (-16.67 %) |
| Aug 19 2014 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Payment of Exercise | F | 351.06 | 1,296 | 454,974 | 23,054 | 24.4 K to 23.1 K (-5.32 %) |
| Aug 19 2014 | REGN | REGENERON PHARMACE ... | Aberman Michael S | VP Strategy and Inv ... | Buy | M | 52.03 | 8,750 | 455,263 | 24,350 | 15.6 K to 24.4 K (+56.09 %) |
| Aug 18 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | M | 52.03 | 5,875 | 305,676 | 9,829 | |
| Aug 18 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Sell | S | 353.00 | 5,875 | 2,073,875 | 3,000 | 8.9 K to 3 K (-66.20 %) |
| Aug 18 2014 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Buy | M | 52.03 | 5,875 | 305,676 | 8,875 | 3 K to 8.9 K (+195.83 %) |
| Aug 18 2014 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Option Exercise | M | 33.42 | 3,000 | 100,260 | 0 | |
| Aug 18 2014 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Gift | G | 0.00 | 2,700 | 0 | 0 | 2.7 K to 0 (-100.00 %) |
| Aug 18 2014 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Sell | S | 349.20 | 3,000 | 1,047,600 | 0 | 3 K to 0 (-100.00 %) |
| Aug 18 2014 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Buy | M | 33.42 | 3,000 | 100,260 | 3,000 | 0 to 3 K |
| Aug 14 2014 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 340.01 | 8,028 | 2,729,600 | 248,540 | 256.6 K to 248.5 K (-3.13 %) |
| Aug 14 2014 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Sell | S | 347.65 | 2,000 | 695,300 | 6,000 | 8 K to 6 K (-25.00 %) |
| Aug 11 2014 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Option Exercise | M | 9.49 | 270,352 | 2,565,640 | 0 | |
| Aug 11 2014 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Gift | G | 0.00 | 756 | 0 | 156,368 | 157.1 K to 156.4 K (-0.48 %) |
| Aug 11 2014 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Gift | G | 0.00 | 700 | 0 | 157,124 | 157.8 K to 157.1 K (-0.44 %) |
| Aug 11 2014 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Gift | G | 0.00 | 764 | 0 | 157,824 | 158.6 K to 157.8 K (-0.48 %) |
| Aug 11 2014 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 341.02 | 300 | 102,306 | 256,568 | 256.9 K to 256.6 K (-0.12 %) |
| Aug 11 2014 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 340.02 | 9,072 | 3,084,661 | 256,868 | 265.9 K to 256.9 K (-3.41 %) |
| Aug 11 2014 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 340.33 | 2,600 | 884,858 | 265,940 | 268.5 K to 265.9 K (-0.97 %) |
| Aug 11 2014 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Payment of Exercise | F | 340.12 | 135,108 | 45,952,933 | 268,540 | 403.6 K to 268.5 K (-33.47 %) |
| Aug 11 2014 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Payment of Exercise | F | 340.12 | 7,543 | 2,565,525 | 403,648 | 411.2 K to 403.6 K (-1.83 %) |
| Aug 11 2014 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Buy | M | 9.49 | 270,352 | 2,565,640 | 411,191 | 140.8 K to 411.2 K (+191.96 %) |
| Aug 11 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Sell | S | 341.27 | 200 | 68,254 | 13,527 | 13.7 K to 13.5 K (-1.46 %) |
| Aug 11 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Sell | S | 340.04 | 9,829 | 3,342,253 | 13,727 | 23.6 K to 13.7 K (-41.73 %) |
| Aug 11 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Sell | S | 339.33 | 1,617 | 548,697 | 23,556 | 25.2 K to 23.6 K (-6.42 %) |
| Aug 08 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Option Exercise | M | 21.25 | 35,000 | 743,750 | 45,295 | |
| Aug 08 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Sell | S | 341.00 | 200 | 68,200 | 25,173 | 25.4 K to 25.2 K (-0.79 %) |
| Aug 08 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Sell | S | 340.60 | 1,900 | 647,140 | 25,373 | 27.3 K to 25.4 K (-6.97 %) |
| Aug 08 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Sell | S | 341.03 | 117 | 39,901 | 27,273 | 27.4 K to 27.3 K (-0.43 %) |
| Aug 08 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Sell | S | 340.39 | 624 | 212,403 | 27,390 | 28 K to 27.4 K (-2.23 %) |
| Aug 08 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Payment of Exercise | F | 336.11 | 18,301 | 6,151,149 | 28,014 | 46.3 K to 28 K (-39.51 %) |
| Aug 08 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Payment of Exercise | F | 336.11 | 2,212 | 743,475 | 46,315 | 48.5 K to 46.3 K (-4.56 %) |
| Aug 08 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Buy | M | 21.25 | 35,000 | 743,750 | 48,527 | 13.5 K to 48.5 K (+258.74 %) |
| Aug 07 2014 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Option Exercise | M | 21.25 | 15,000 | 318,750 | 56,595 | |
| Aug 07 2014 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 338.37 | 6,806 | 2,302,946 | 15,441 | 22.2 K to 15.4 K (-30.59 %) |
| Aug 07 2014 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Payment of Exercise | F | 336.11 | 7,246 | 2,435,453 | 22,247 | 29.5 K to 22.2 K (-24.57 %) |
| Aug 07 2014 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Payment of Exercise | F | 336.11 | 948 | 318,632 | 29,493 | 30.4 K to 29.5 K (-3.11 %) |
| Aug 07 2014 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Buy | M | 21.25 | 15,000 | 318,750 | 30,441 | 15.4 K to 30.4 K (+97.14 %) |
| Aug 06 2014 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Sell | S | 331.20 | 2,000 | 662,400 | 8,000 | 10 K to 8 K (-20.00 %) |
| Aug 05 2014 | REGN | REGENERON PHARMACE ... | REGENERON PHARMACEUTICALS INC | 10% Owner | Option Exercise | C | 0.00 | 531,208 | 0 | 0 | |
| Aug 05 2014 | REGN | REGENERON PHARMACE ... | REGENERON PHARMACEUTICALS INC | 10% Owner | Option Exercise | C | 0.00 | 689,655 | 0 | 0 | |
| Aug 05 2014 | REGN | REGENERON PHARMACE ... | REGENERON PHARMACEUTICALS INC | 10% Owner | Buy | P | 17.00 | 588,235 | 9,999,995 | 1,809,098 | 1.2 M to 1.8 M (+48.18 %) |
| Aug 05 2014 | REGN | REGENERON PHARMACE ... | REGENERON PHARMACEUTICALS INC | 10% Owner | Buy | C | 0.00 | 531,208 | 0 | 1,220,863 | 689.7 K to 1.2 M (+77.03 %) |
| Aug 05 2014 | REGN | REGENERON PHARMACE ... | REGENERON PHARMACEUTICALS INC | 10% Owner | Buy | C | 0.00 | 689,655 | 0 | 689,655 | 0 to 689.7 K |